Deutsche Bank Ag\ Dr Reddys Laboratories LTD Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Deutsche Bank Ag\ holds 41,666 shares of RDY stock, worth $591,657. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,666

Previous 47,849 12.92%

Holding current value

$591,657

Previous $3.65 Million 9.19%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$75.41 - $84.21 $466,260 - $520,670	-6,183 Reduced 12.92%	41,666 $3.31 Million
Q2 2024 Aug 14, 2024	SELL	$68.26 - $76.19 $2.09 Million - $2.33 Million	-30,557 Reduced 38.97%	47,849 $3.65 Million
Q1 2024 May 15, 2024	BUY	$67.36 - $77.59 $68,235 - $78,598	1,013 Added 1.31%	78,406 $5.75 Million
Q4 2023 Feb 14, 2024	SELL	$64.27 - $69.9 $590,255 - $641,961	-9,184 Reduced 10.61%	77,393 $5.39 Million
Q3 2023 Nov 09, 2023	SELL	$61.9 - $72.77 $1.76 Million - $2.07 Million	-28,469 Reduced 24.75%	86,577 $5.79 Million
Q2 2023 Aug 14, 2023	BUY	$53.34 - $63.11 $172,714 - $204,350	3,238 Added 2.9%	115,046 $7.26 Million
Q1 2023 May 15, 2023	SELL	$51.63 - $56.93 $201,357 - $222,027	-3,900 Reduced 3.37%	111,808 $6.37 Million
Q4 2022 Feb 13, 2023	SELL	$51.15 - $57.45 $377,793 - $424,325	-7,386 Reduced 6.0%	115,708 $5.99 Million
Q3 2022 Nov 14, 2022	SELL	$49.9 - $57.32 $163,472 - $187,780	-3,276 Reduced 2.59%	123,094 $6.44 Million
Q2 2022 Aug 11, 2022	SELL	$49.62 - $58.13 $87,033 - $101,960	-1,754 Reduced 1.37%	126,370 $7 Million
Q1 2022 May 13, 2022	BUY	$48.27 - $65.25 $111,358 - $150,531	2,307 Added 1.83%	128,124 $7.14 Million
Q4 2021 Feb 11, 2022	BUY	$59.5 - $67.25 $108,409 - $122,529	1,822 Added 1.47%	125,817 $8.23 Million
Q3 2021 Nov 04, 2021	SELL	$60.19 - $75.29 $530,394 - $663,455	-8,812 Reduced 6.64%	123,995 $8.08 Million
Q2 2021 Aug 11, 2021	BUY	$62.12 - $74.2 $959,194 - $1.15 Million	15,441 Added 13.16%	132,807 $9.76 Million
Q1 2021 May 13, 2021	BUY	$57.98 - $73.08 $466,681 - $588,220	8,049 Added 7.36%	117,366 $7.21 Million
Q4 2020 Feb 16, 2021	BUY	$62.61 - $71.29 $1.65 Million - $1.88 Million	26,416 Added 31.86%	109,317 $7.79 Million
Q3 2020 Nov 12, 2020	BUY	$51.39 - $72.41 $2.08 Million - $2.93 Million	40,466 Added 95.36%	82,901 $5.77 Million
Q2 2020 Aug 13, 2020	SELL	$39.55 - $54.65 $455,378 - $629,240	-11,514 Reduced 21.34%	42,435 $2.25 Million
Q1 2020 May 14, 2020	BUY	$34.75 - $45.85 $376,551 - $496,830	10,836 Added 25.13%	53,949 $2.18 Million
Q4 2019 Feb 14, 2020	SELL	$36.66 - $41.78 $1.1 Million - $1.25 Million	-29,900 Reduced 40.95%	43,113 $1.75 Million
Q3 2019 Nov 14, 2019	SELL	$34.82 - $39.26 $597,163 - $673,309	-17,150 Reduced 19.02%	73,013 $2.76 Million
Q2 2019 Aug 14, 2019	BUY	$36.05 - $42.76 $627,125 - $743,852	17,396 Added 23.91%	90,163 $3.38 Million
Q1 2019 May 15, 2019	SELL	$35.77 - $40.57 $18,886 - $21,420	-528 Reduced 0.72%	72,767 $2.94 Million
Q4 2018 Feb 14, 2019	SELL	$31.89 - $38.44 $4.43 Million - $5.34 Million	-138,899 Reduced 65.46%	73,295 $2.76 Million
Q3 2018 Nov 14, 2018	SELL	$29.25 - $36.73 $8.06 Million - $10.1 Million	-275,725 Reduced 56.51%	212,194 $7.34 Million
Q2 2018 Aug 14, 2018	SELL	$28.49 - $35.06 $1.04 Million - $1.28 Million	-36,548 Reduced 6.97%	487,919 $15.7 Million
Q1 2018 Oct 18, 2019	BUY	$31.93 - $39.54 $168,654 - $208,850	5,282 Added 1.02%	524,467 $17.1 Million
Q1 2018 May 15, 2018	BUY	$31.93 - $39.54 $5.73 Million - $7.1 Million	179,584 Added 52.88%	519,185 $17 Million
Q4 2017 Feb 14, 2018	SELL	$34.15 - $37.62 $4.29 Million - $4.72 Million	-125,589 Reduced 27.0%	339,601 $12.8 Million
Q3 2017 Nov 14, 2017	BUY	$30.11 - $37.72 $14 Million - $17.5 Million	465,190	465,190 $16.6 Million

Others Institutions Holding RDY

# of Institutions

244

Shares Held

23.2M

Call Options Held

12.7K

Put Options Held

6.1K

View Full List

About DR REDDYS LABORATORIES LTD

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.36B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

More about RDY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account